Link | RSS | 5 months ago

The Economist Morning Briefing, June 19th, 2021

The delta variant’s rise and an AstraZeneca-EU ruling  See acast.com/privacy for privacy and opt-out information.

Link | RSS | 6 months ago

May 13 2021 — The fight over Line 5 continues

The fight over Line 5 continues; The future of the AstraZeneca vaccine in Canada is in question; And roughly 88,000 international air travellers were exempted from staying in Canada’s quarantine hotels, but the government won’t say why.

Link | RSS | 6 months ago

AstraZeneca concerns. Decriminalizing drugs.

With three provinces having paused rollout of the AstraZeneca COVID-19 vaccine due in part to safety concerns, Dr. Brian Conway and Dr. Madhu Jawanda answer your questions about COVID vaccines. As the City of Vancouver works to secure a federal exemption to decriminalize drug possession, VANDU member Garth Mullins and …

Link | RSS | 6 months ago

The Economist Morning Briefing, May 10th, 2021

America declares an emergency after ransomware attack and the EU ditches AstraZeneca  See acast.com/privacy for privacy and opt-out information.

Link | RSS | 7 months ago

Boeing's Latest 737 MAX Problem Prompts an FAA Audit

AstraZeneca struggles to gather the full data needed to apply for U.S. emergency-use authorization of its Covid-19 vaccine. In Israel, dozens are killed in a stampede at a religious festival. Keith Collins hosts.Learn more about your ad choices. Visit megaphone.fm/adchoices

Link | RSS | 7 months ago

COVID-19 vaccines and blood clots explained

As the rollout of the Johnson & Johnson and AstraZeneca COVID-19 vaccines face hurdles around the world, we take a look at the science behind the shots and the risk of "extremely rare" blood clots.

Link | RSS | 7 months ago

Two New Studies Point to How AstraZeneca’s COVID-19 Vaccine Is Linked to Blood Clots

In two papers published in the New England Journal of Medicine (NEJM), researchers in Europe provide the most detailed explanation yet for what is behind the clotting side effects reported among people getting vaccinated with the AstraZeneca COVID-19 shot. In both papers, researchers found that people getting the va …

Link | RSS | 7 months ago

Clotting factors: the AstraZeneca vaccine

British and European regulators have addressed a possible link with blood clots. Expect more rare side-effects to emerge; what seems clear for now is that the vaccine’s benefits outweigh any risks. A new analysis shows that a racist American film from 1915 left a long legacy of racial violence. And a shady history of t …

Link | RSS | 7 months ago

What do we know about blood clots and the AstraZeneca Covid vaccine?

The rollout of the Oxford-AstraZeneca Covid vaccine hasn’t been straightforward. After weathering early questions about its efficacy, there has been a series of rare blood clotting incidents, resulting in several deaths overseas. As authorities investigate whether the vaccine is responsible, some countries have paused …

Link | RSS | 7 months ago

The RSB Show 4-6-21 - New normal, AstraZeneca, Celia Farber, CDC death rates, John Magufuli

The RSB Show 4-6-21 - New normal, AstraZeneca blood clots, Celia Farber, CDC death rates, John Magufuli Death of an African Freedom Fighter

Link | RSS | 8 months ago

Episode 50: Hot News!

More Coronavirus news, CDC says cases are spiking again. Problems with the AstraZeneca vaccine. Bernie Sanders vs. Jeff Bezos. White Headmaster of N.Y. school forces 11 year old black boy to kneel in apology to teacher. Radio host Rob Lederman fired for talking about skin tone on the air. Join us for these topics …

Link | RSS | 8 months ago

U.S. Stocks Edge Down as Investors Sell Tech Shares

Plus: AstraZeneca's Covid-19 vaccine faces fresh ban in Germany for people under 60. Federal Trade Commission challenges Illumina's planned acquisition of Grail. Charlie Turner reports.Learn more about your ad choices. Visit megaphone.fm/adchoices

Link | RSS | 8 months ago

Podcast: This Week in Managed Care—AZ Updates Vaccine Efficacy Data and Other Health News

This week, the top managed care news included efficacy data on AstraZeneca’s COVID-19 vaccine questioned; coverage from the NCCN 2021 Virtual Annual Conference; COVID-19 poses risks to children with poorly controlled type 1 diabetes.

Link | RSS | 8 months ago

Coronapod: the Oxford-AstraZeneca COVID vaccine - what you need to know

Since the beginning of the pandemic the Oxford-AstraZeneca vaccine has been plagued by confusion and controversy. The vaccine has been authorised in over 100 countries, tens of millions of doses have been administered, and it has been demonstrated to be safe and effective. However, over the past few weeks the vaccine h …

Link | RSS | 8 months ago


Hamilton! She pushed through her normal reticence about musical theatre to revel in the joy and dynamism that is Hamilton. Also this week, what are the pros and cons of a (non-alcoholic) liquid lunch? Has yoga changed in the wake of the pandemic? Geraldine's found a new Boris Johnson critic to rival Fintan O'Toole. An …


RN Breakfast - separate stories

Link | RSS

The Economist Morning Briefing

Link | RSS

The Robert Scott Bell Show

Link | RSS

CPAC Today in Politics

Link | RSS

Interested to learn more?

Get in touch below to learn more about Mixtape.

The name is required.
The name can be up to 50 characters long.
Name: {{newContact.name}}
The email is required.
The email is not valid.
Email: {{newContact.email}}
The message can be up to 280 characters long.

About Mixtape

Podcasts have seen in the recent years a steady increase in numbers, both in terms of listeners and content providers. With over 42 million episodes available in January 2021, finding the podcast episodes to listen to is one of the main issues that listeners face. The problem is that podcasts are generally organised in lists and catalogues for listeners to subscribe to, or they are sorted based on popularity.

In MIXTAPE we improve the way podcasts are searched by allowing listeners to find content based on topics of interest. For the first time it is possible to find individual podcast episodes based on your preferences and precise interests. To enable this we use speech processing and natural language understanding and add these key components to our existing content management platform.